[HTML][HTML] Nothing but NET: a review of neuroendocrine tumors and carcinomas
B Oronsky, PC Ma, D Morgensztern, CA Carter - Neoplasia, 2017 - Elsevier
This review covers the diverse topic of neuroendocrine neoplasms (NENs), a relatively rare
and heterogeneous tumor type, comprising~ 2% of all malignancies, with a prevalence of< …
and heterogeneous tumor type, comprising~ 2% of all malignancies, with a prevalence of< …
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame
V Marotta, MC Zatelli, C Sciammarella… - Endocrine-related …, 2018 - erc.bioscientifica.com
Owing to the heterogeneity of neuroendocrine neoplasms (NENs), the availability of reliable
circulating markers is critical for improving diagnostics, prognostic stratification, follow-up …
circulating markers is critical for improving diagnostics, prognostic stratification, follow-up …
The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors
JR Howe, NB Merchant, C Conrad, XM Keutgen… - Pancreas, 2020 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …
consensus conference on the surgical management of pancreatic neuroendocrine tumors …
Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases
BACKGROUND Extrapulmonary neuroendocrine carcinomas (NECs) are poorly studied and
are managed similar to lung NECs, which may not account for differences between the 2 …
are managed similar to lung NECs, which may not account for differences between the 2 …
Alternative lengthening of telomeres and loss of DAXX/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine …
Abstract Purpose: Pancreatic neuroendocrine tumors (PanNET) are a heterogeneous group
of neoplasms with increasing incidence and unpredictable behavior. Whole-exome …
of neoplasms with increasing incidence and unpredictable behavior. Whole-exome …
NANETS/SNMMI procedure standard for somatostatin receptor–based peptide receptor radionuclide therapy with 177Lu-DOTATATE
TA Hope, A Abbott, K Colucci, DL Bushnell… - Journal of Nuclear …, 2019 - Soc Nuclear Med
With the recent approval of 177Lu-DOTATATE for use in gastroenteropancreatic
neuroendocrine tumors, access to peptide receptor radionuclide therapy is increasing …
neuroendocrine tumors, access to peptide receptor radionuclide therapy is increasing …
INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors
The head and neck is the site of a wide and sometimes bewildering array of neuroendocrine
(NE) tumors. Although recognition of NE differentiation may be necessary for appropriate …
(NE) tumors. Although recognition of NE differentiation may be necessary for appropriate …
Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts
JY Kim, SM Hong - Archives of pathology & laboratory …, 2016 - meridian.allenpress.com
Context.—Gastrointestinal (GI) and pancreatobiliary tracts contain a variety of
neuroendocrine cells that constitute a diffuse endocrine system. Neuroendocrine tumors …
neuroendocrine cells that constitute a diffuse endocrine system. Neuroendocrine tumors …
[HTML][HTML] Management of gastric and duodenal neuroendocrine tumors
Y Sato, S Hashimoto, K Mizuno… - World journal of …, 2016 - ncbi.nlm.nih.gov
Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, like all NETs.
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma
A Berruti, S Grisanti, A Pulzer, M Claps… - The Journal of …, 2017 - academic.oup.com
Context: In 2007, a retrospective case-control study provided evidence that adjuvant
mitotane prolongs recurrence-free survival (RFS) in patients with radically resected …
mitotane prolongs recurrence-free survival (RFS) in patients with radically resected …